How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
62
THC Quote, Financials, Valuation and Earnings
Last price:
$134.62
Seasonality move
:
5.42%
Day range:
$131.01 - $135.76
52-week range:
$90.03 - $171.20
Dividend yield:
0%
P/E ratio:
4.17x
P/S ratio:
0.64x
P/B ratio:
3.07x
Volume:
1.1M
Avg. volume:
1.7M
1-year change:
27.96%
Market cap:
$12.8B
Revenue:
$20.7B
EPS (TTM):
$32.23
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.6B | $19.5B | $19.2B | $20.5B | $20.7B | |
| Revenue Growth (YoY) | -4.54% | 10.46% | -1.6% | 7.17% | 0.57% | |
| Cost of Revenues | $3B | $3.3B | $3.3B | $3.6B | $3.6B | |
| Gross Profit | $14.7B | $16.2B | $15.9B | $17B | $17B | |
| Gross Profit Margin | 83.1% | 82.92% | 82.93% | 82.53% | 82.35% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.4B | $8.9B | $8.8B | $9.1B | $8.8B | |
| Other Inc / (Exp) | -$466M | $402M | -$177M | $75M | $3.2B | |
| Operating Expenses | $12.5B | $13.7B | $13.5B | $14.5B | $14.1B | |
| Operating Income | $2.1B | $2.4B | $2.4B | $2.4B | $2.9B | |
| Net Interest Expenses | $1B | $923M | $890M | $901M | $826M | |
| EBT. Incl. Unusual Items | $671M | $1.9B | $1.3B | $1.6B | $5.2B | |
| Earnings of Discontinued Ops. | -- | -$1M | $1M | -- | -- | |
| Income Tax Expense | -$97M | $411M | $344M | $306M | $1.2B | |
| Net Income to Company | $768M | $1.5B | $1B | $1.3B | $4.1B | |
| Minority Interest in Earnings | -$369M | -$562M | -$590M | -$700M | -$864M | |
| Net Income to Common Excl Extra Items | $399M | $914M | $411M | $611M | $3.2B | |
| Basic EPS (Cont. Ops) | $3.80 | $8.55 | $3.84 | $6.01 | $33.02 | |
| Diluted EPS (Cont. Ops) | $3.75 | $8.42 | $3.79 | $5.71 | $32.70 | |
| Weighted Average Basic Share | $105M | $106.8M | $106.9M | $101.6M | $96.9M | |
| Weighted Average Diluted Share | $106.3M | $108.6M | $110.5M | $104.8M | $97.9M | |
| EBITDA | $2.5B | $3.7B | $3.1B | $3.4B | $6.9B | |
| EBIT | $1.7B | $2.8B | $2.2B | $2.5B | $6.1B | |
| Revenue (Reported) | $17.6B | $19.5B | $19.2B | $20.5B | $20.7B | |
| Operating Income (Reported) | $2.1B | $2.4B | $2.4B | $2.4B | $2.9B | |
| Operating Income (Adjusted) | $1.7B | $2.8B | $2.2B | $2.5B | $6.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.9B | $5B | $5.4B | $5.1B | |
| Revenue Growth (YoY) | 2.27% | -1.2% | 2.76% | 7.8% | -5.71% | |
| Cost of Revenues | $824M | $838M | $860M | $931M | $930M | |
| Gross Profit | $4.1B | $4B | $4.1B | $4.4B | $4.1B | |
| Gross Profit Margin | 83.24% | 82.74% | 82.77% | 82.69% | 81.66% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.2B | $2.2B | $2.3B | $2.3B | $2.1B | |
| Other Inc / (Exp) | -$526M | $11M | -$78M | $23M | $81M | |
| Operating Expenses | $2.6B | $3.3B | $3.5B | $3.7B | $3.4B | |
| Operating Income | $1.4B | $738M | $619M | $723M | $777M | |
| Net Interest Expenses | $242M | $221M | $219M | $227M | $203M | |
| EBT. Incl. Unusual Items | $676M | $528M | $322M | $519M | $655M | |
| Earnings of Discontinued Ops. | -- | -$1M | -- | -- | -- | |
| Income Tax Expense | $130M | $108M | $47M | $63M | $83M | |
| Net Income to Company | $546M | $419M | $274M | $456M | $572M | |
| Minority Interest in Earnings | -$132M | -$170M | -$172M | -$212M | -$254M | |
| Net Income to Common Excl Extra Items | $414M | $249M | $102M | $244M | $318M | |
| Basic EPS (Cont. Ops) | $3.92 | $2.32 | $0.98 | $2.42 | $3.34 | |
| Diluted EPS (Cont. Ops) | $3.86 | $2.29 | $0.92 | $2.30 | $3.32 | |
| Weighted Average Basic Share | $105.6M | $107.2M | $104.5M | $100.9M | $95.1M | |
| Weighted Average Diluted Share | $110.6M | $108.9M | $105.2M | $104.1M | $96M | |
| EBITDA | $1.2B | $950M | $754M | $962M | $1.1B | |
| EBIT | $918M | $749M | $541M | $746M | $858M | |
| Revenue (Reported) | $4.9B | $4.9B | $5B | $5.4B | $5.1B | |
| Operating Income (Reported) | $1.4B | $738M | $619M | $723M | $777M | |
| Operating Income (Adjusted) | $918M | $749M | $541M | $746M | $858M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.6B | $19.5B | $19.2B | $20.5B | $20.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3B | $3.3B | $3.3B | $3.6B | $3.6B | |
| Gross Profit | $14.7B | $16.2B | $15.9B | $17B | $17B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.4B | $8.9B | $8.8B | $9.1B | $8.8B | |
| Other Inc / (Exp) | -$977M | $402M | -$177M | $75M | $3.2B | |
| Operating Expenses | $12B | $13.7B | $13.5B | $14.5B | $14.1B | |
| Operating Income | $2.7B | $2.4B | $2.4B | $2.4B | $2.9B | |
| Net Interest Expenses | $1B | $923M | $890M | $901M | $826M | |
| EBT. Incl. Unusual Items | $671M | $1.9B | $1.3B | $1.6B | $5.2B | |
| Earnings of Discontinued Ops. | -- | -$1M | $1M | -- | -- | |
| Income Tax Expense | -$97M | $411M | $344M | $306M | $1.2B | |
| Net Income to Company | $768M | $1.5B | $1B | $1.3B | $4.1B | |
| Minority Interest in Earnings | -$369M | -$562M | -$590M | -$700M | -$864M | |
| Net Income to Common Excl Extra Items | $399M | $914M | $411M | $611M | $3.2B | |
| Basic EPS (Cont. Ops) | $3.79 | $8.53 | $3.84 | $6.02 | $32.53 | |
| Diluted EPS (Cont. Ops) | $3.71 | $8.42 | $3.71 | $5.71 | $32.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.5B | $3.7B | $3.1B | $3.4B | $6.9B | |
| EBIT | $1.7B | $2.8B | $2.2B | $2.5B | $6.1B | |
| Revenue (Reported) | $17.6B | $19.5B | $19.2B | $20.5B | $20.7B | |
| Operating Income (Reported) | $2.7B | $2.4B | $2.4B | $2.4B | $2.9B | |
| Operating Income (Adjusted) | $1.7B | $2.8B | $2.2B | $2.5B | $6.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19.5B | $19.2B | $20.5B | $20.7B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.3B | $3.3B | $3.6B | $3.6B | -- | |
| Gross Profit | $16.2B | $15.9B | $17B | $17B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.9B | $8.8B | $9.1B | $8.8B | -- | |
| Other Inc / (Exp) | $402M | -$177M | $75M | $3.2B | -- | |
| Operating Expenses | $13.7B | $13.5B | $14.5B | $14.1B | -- | |
| Operating Income | $2.4B | $2.4B | $2.4B | $2.9B | -- | |
| Net Interest Expenses | $923M | $890M | $901M | $826M | -- | |
| EBT. Incl. Unusual Items | $1.9B | $1.3B | $1.6B | $5.2B | -- | |
| Earnings of Discontinued Ops. | -$1M | $1M | -- | -- | -- | |
| Income Tax Expense | $411M | $344M | $306M | $1.2B | -- | |
| Net Income to Company | $1.5B | $1B | $1.3B | $4.1B | -- | |
| Minority Interest in Earnings | -$562M | -$590M | -$700M | -$864M | -- | |
| Net Income to Common Excl Extra Items | $914M | $411M | $611M | $3.2B | -- | |
| Basic EPS (Cont. Ops) | $8.53 | $3.84 | $6.02 | $32.53 | -- | |
| Diluted EPS (Cont. Ops) | $8.42 | $3.71 | $5.71 | $32.23 | -- | |
| Weighted Average Basic Share | $427.3M | $427.7M | $406.5M | $387.6M | -- | |
| Weighted Average Diluted Share | $434.3M | $435.9M | $419.3M | $391.7M | -- | |
| EBITDA | $3.7B | $3.1B | $3.4B | $6.9B | -- | |
| EBIT | $2.8B | $2.2B | $2.5B | $6.1B | -- | |
| Revenue (Reported) | $19.5B | $19.2B | $20.5B | $20.7B | -- | |
| Operating Income (Reported) | $2.4B | $2.4B | $2.4B | $2.9B | -- | |
| Operating Income (Adjusted) | $2.8B | $2.2B | $2.5B | $6.1B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $2.4B | $858M | $1.2B | $3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.7B | $2.8B | $2.9B | $2.9B | $2.5B | |
| Inventory | $368M | $384M | $405M | $411M | $346M | |
| Prepaid Expenses | -- | $252M | $400M | $391M | $368M | |
| Other Current Assets | $1.5B | $158M | $231M | $369M | $313M | |
| Total Current Assets | $7.1B | $7.1B | $6B | $7.2B | $7.7B | |
| Property Plant And Equipment | $7.9B | $7.4B | $7.6B | $7.3B | $7.1B | |
| Long-Term Investments | $1B | $1.8B | $1.6B | $1.6B | $1.5B | |
| Goodwill | $8.8B | $9.3B | $10.1B | $10.3B | $10.7B | |
| Other Intangibles | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B | |
| Other Long-Term Assets | $42M | $47M | $37M | $43M | $48M | |
| Total Assets | $27.1B | $27.6B | $27.2B | $28.3B | $28.9B | |
| Accounts Payable | $1.2B | $1.3B | $1.5B | $1.4B | $1.3B | |
| Accrued Expenses | $248M | $203M | $213M | $200M | $149M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.4B | $1.4B | $1.6B | $1.8B | $1.6B | |
| Total Current Liabilities | $4.8B | $5.1B | $4.5B | $4.8B | $4.3B | |
| Long-Term Debt | $15.6B | $15.5B | $14.9B | $14.9B | $13.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.2B | $23.3B | $22.5B | $22.8B | $20.4B | |
| Common Stock | $7M | $8M | $8M | $8M | $8M | |
| Other Common Equity Adj | -$281M | -$233M | -$181M | -$181M | -$180M | |
| Common Equity | $28M | $1B | $1.1B | $1.6B | $4.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.9B | $3.2B | $3.5B | $3.9B | $4.4B | |
| Total Equity | $2.9B | $4.3B | $4.6B | $5.5B | $8.5B | |
| Total Liabilities and Equity | $27.1B | $27.6B | $27.2B | $28.3B | $28.9B | |
| Cash and Short Terms | $2.4B | $2.4B | $858M | $1.2B | $3B | |
| Total Debt | $15.7B | $15.6B | $15.1B | $15B | $13.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $2.4B | $858M | $1.2B | $3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.7B | $2.8B | $2.9B | $2.9B | $2.5B | |
| Inventory | $368M | $384M | $405M | $411M | $346M | |
| Prepaid Expenses | -- | $252M | $400M | $391M | $368M | |
| Other Current Assets | $1.5B | $158M | $231M | $369M | $313M | |
| Total Current Assets | $7.1B | $7.1B | $6B | $7.2B | $7.7B | |
| Property Plant And Equipment | $7.9B | $7.4B | $7.6B | $7.3B | $7.1B | |
| Long-Term Investments | $1B | $1.8B | $1.6B | $1.6B | $1.5B | |
| Goodwill | $8.8B | $9.3B | $10.1B | $10.3B | $10.7B | |
| Other Intangibles | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B | |
| Other Long-Term Assets | $42M | $47M | $37M | $43M | $48M | |
| Total Assets | $27.1B | $27.6B | $27.2B | $28.3B | $28.9B | |
| Accounts Payable | $1.2B | $1.3B | $1.5B | $1.4B | $1.3B | |
| Accrued Expenses | $248M | $203M | $213M | $200M | $149M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.4B | $1.4B | $1.6B | $1.8B | $1.6B | |
| Total Current Liabilities | $4.8B | $5.1B | $4.5B | $4.8B | $4.3B | |
| Long-Term Debt | $15.6B | $15.5B | $14.9B | $14.9B | $13.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.2B | $23.3B | $22.5B | $22.8B | $20.4B | |
| Common Stock | $7M | $8M | $8M | $8M | $8M | |
| Other Common Equity Adj | -$281M | -$233M | -$181M | -$181M | -$180M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.9B | $3.2B | $3.5B | $3.9B | $4.4B | |
| Total Equity | $2.9B | $4.3B | $4.6B | $5.5B | $8.5B | |
| Total Liabilities and Equity | $27.1B | $27.6B | $27.2B | $28.3B | $28.9B | |
| Cash and Short Terms | $2.4B | $2.4B | $858M | $1.2B | $3B | |
| Total Debt | $15.7B | $15.6B | $15.1B | $15B | $13.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $768M | $1.5B | $1B | $1.3B | $4.1B | |
| Depreciation & Amoritzation | $857M | $855M | $841M | $870M | $818M | |
| Stock-Based Compensation | $44M | $56M | $56M | $66M | $67M | |
| Change in Accounts Receivable | $195M | -$197M | -$140M | -$29M | $245M | |
| Change in Inventories | -$145M | -$52M | -$64M | -$139M | -$86M | |
| Cash From Operations | $3.4B | $1.6B | $1.1B | $2.4B | $2B | |
| Capital Expenditures | $540M | $658M | $762M | $751M | $931M | |
| Cash Acquisitions | -$1.2B | -$1.2B | -$234M | -$224M | -$571M | |
| Cash From Investing | -$1.6B | -$714M | -$808M | -$969M | $3.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.6B | $2.9B | $2B | $1.4B | $23M | |
| Long-Term Debt Repaid | -$4B | -$3.2B | -$2.9B | -$1.5B | -$2.2B | |
| Repurchase of Common Stock | -- | -- | -$250M | -$200M | -$672M | |
| Other Financing Activities | -$140M | -$587M | -$703M | -$663M | -$793M | |
| Cash From Financing | $385M | -$936M | -$1.8B | -$1B | -$3.7B | |
| Beginning Cash (CF) | $262M | $2.4B | $2.4B | $858M | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.2B | -$82M | -$1.5B | $370M | $1.8B | |
| Ending Cash (CF) | $2.4B | $2.4B | $858M | $1.2B | $3B | |
| Levered Free Cash Flow | $2.9B | $910M | $321M | $1.6B | $1.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $546M | $419M | $274M | $456M | $572M | |
| Depreciation & Amoritzation | $233M | $201M | $213M | $216M | $193M | |
| Stock-Based Compensation | $6M | $13M | $9M | $18M | $15M | |
| Change in Accounts Receivable | -$85M | $5M | -$101M | -$60M | $62M | |
| Change in Inventories | -$175M | $59M | -$153M | -$90M | -$96M | |
| Cash From Operations | $446M | $357M | $421M | $824M | -$331M | |
| Capital Expenditures | $166M | $304M | $290M | $208M | $330M | |
| Cash Acquisitions | -$1.1B | -$1.2B | -$10M | -$114M | -$47M | |
| Cash From Investing | -$1.2B | -$1.5B | -$306M | -$333M | -$372M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3M | $1.5B | $3M | $2M | $7M | |
| Long-Term Debt Repaid | -$49M | -$38M | -$65M | -$64M | -$31M | |
| Repurchase of Common Stock | -- | -- | -$250M | -$110M | -- | |
| Other Financing Activities | -$39M | -$190M | -$153M | -$145M | -$348M | |
| Cash From Financing | -$98M | $1.2B | -$465M | -$317M | -$372M | |
| Beginning Cash (CF) | $3.3B | $2.3B | $1.2B | $1.1B | $4.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$854M | $72M | -$350M | $174M | -$1.1B | |
| Ending Cash (CF) | $2.4B | $2.4B | $858M | $1.2B | $3B | |
| Levered Free Cash Flow | $280M | $53M | $131M | $616M | -$661M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $768M | $1.5B | $1B | $1.3B | $4.1B | |
| Depreciation & Amoritzation | $857M | $855M | $841M | $870M | $818M | |
| Stock-Based Compensation | $44M | $56M | $56M | $66M | $67M | |
| Change in Accounts Receivable | $195M | -$197M | -$140M | -$29M | $245M | |
| Change in Inventories | -$145M | -$52M | -$64M | -$139M | -$86M | |
| Cash From Operations | $3.4B | $1.6B | $1.1B | $2.4B | $2B | |
| Capital Expenditures | $540M | $658M | $762M | $751M | $931M | |
| Cash Acquisitions | -$1.2B | -$1.2B | -$234M | -$224M | -$571M | |
| Cash From Investing | -$1.6B | -$714M | -$808M | -$969M | $3.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.6B | $2.9B | $2B | $1.4B | $23M | |
| Long-Term Debt Repaid | -$4B | -$3.2B | -$2.9B | -$1.5B | -$2.2B | |
| Repurchase of Common Stock | -- | -- | -$250M | -$200M | -$672M | |
| Other Financing Activities | -$140M | -$587M | -$703M | -$663M | -$793M | |
| Cash From Financing | $385M | -$936M | -$1.8B | -$1B | -$3.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.2B | -$82M | -$1.5B | $370M | $1.8B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.9B | $910M | $321M | $1.6B | $1.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $1B | $1.3B | $4.1B | -- | |
| Depreciation & Amoritzation | $855M | $841M | $870M | $818M | -- | |
| Stock-Based Compensation | $56M | $56M | $66M | $67M | -- | |
| Change in Accounts Receivable | -$197M | -$140M | -$29M | $245M | -- | |
| Change in Inventories | -$52M | -$64M | -$139M | -$86M | -- | |
| Cash From Operations | $1.6B | $1.1B | $2.4B | $2B | -- | |
| Capital Expenditures | $658M | $762M | $751M | $931M | -- | |
| Cash Acquisitions | -$1.2B | -$234M | -$224M | -$571M | -- | |
| Cash From Investing | -$714M | -$808M | -$969M | $3.4B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.9B | $2B | $1.4B | $23M | -- | |
| Long-Term Debt Repaid | -$3.2B | -$2.9B | -$1.5B | -$2.2B | -- | |
| Repurchase of Common Stock | -- | -$250M | -$200M | -$672M | -- | |
| Other Financing Activities | -$587M | -$703M | -$663M | -$793M | -- | |
| Cash From Financing | -$936M | -$1.8B | -$1B | -$3.7B | -- | |
| Beginning Cash (CF) | $9.1B | $6.3B | $3.6B | $10.7B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$82M | -$1.5B | $370M | $1.8B | -- | |
| Ending Cash (CF) | $9B | $4.8B | $4B | $12.5B | -- | |
| Levered Free Cash Flow | $910M | $321M | $1.6B | $1.1B | -- | |
Get THC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
THC
Sector
P/E ratio
4.17x
24.26x
PEG ratio
0.01x
0.00x
P/B ratio
3.07x
1.67x
Price / LTM sales
0.64x
1.69x
Growth Metrics
THC
Sector
Revenue growth
-5.71%
6.42%
Earnings growth
44.35%
6.56%
Revenue (5-year growth)
2.26%
8.84%
Earnings forecast
$3.17
-$0.19
Profitability
THC
Sector
Profitability FY 2024
$17B
$56.7M
Return on invested capital
15.32%
-14.34%
Return on assets
11.05%
-11.83%
Return on equity
42.47%
-16.73%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
Apr
30
Estimated Next Earnings Date
May
14
Balance Sheet
THC
Sector
Total cash
$3B
$41.7M
Short term investments
--
$39.3M
Total assets
$28.9B
$125M
Long term debt
$13.2B
$10.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
